AMBI

AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI

Overview Fund Activity
Delisted

AMBI was delisted on the 10th of November, 2014.

Back to rankings

15 hedge funds and large institutions have $36.9M invested in AMBIT BIOSCIENCES CORP COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 15 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
15
Holders Change
+15
Holders Change %
–
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
15
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
O
1
OrbiMed
New York
$10.4M
2
JRJ
2
Jeffrey R. Jay
$7M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$5.62M
4
BBA
4
Baker Bros. Advisors
New York
$5.24M
5
WC
5
Wexford Capital
Florida
$4.36M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$10.4M 1,490,769 +1,490,769 New
JRJ
2
Jeffrey R. Jay
$7M 1,000,000 +1,000,000 New
Fidelity Investments
3
Fidelity Investments
Massachusetts
$5.62M 802,250 +802,250 New
BBA
4
Baker Bros. Advisors
New York
$5.24M 747,962 +747,962 New
WC
5
Wexford Capital
Florida
$4.36M 622,500 +622,500 New
JPMorgan Chase & Co
6
JPMorgan Chase & Co
New York
$1.53M 218,300 +218,300 New
PRCM
7
Pine River Capital Management
Minnesota
$1.22M 174,100 +174,100 New
Alyeska Investment Group
8
Alyeska Investment Group
Illinois
$525K 74,989 +74,989 New
FM
9
Forward Management
California
$408K 57,000 +57,000 New
Goldman Sachs
10
Goldman Sachs
New York
$184K 26,297 +26,297 New
Morgan Stanley
11
Morgan Stanley
New York
$174K 24,834 +24,834 New
SIP
12
Stoneridge Investment Partners
Pennsylvania
$153K 21,906 +21,906 New
TRCT
13
Tower Research Capital (TRC)
New York
$29K 4,144 +4,144 New
Citigroup
14
Citigroup
New York
$1K 150 +150 New
TCM
15
Tang Capital Management
California
$0 46 +46 New